Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Long life supercapacitor R&D programme

21 Dec 2015 11:00

RNS Number : 7203J
CAP-XX Limited
21 December 2015
 

21 December 2015

CAP-XX Limited

("CAP-XX" or "the Company")

Long life supercapacitor R&D programme

 

CAP-XX announces that as part of its ongoing R&D programme, it is in the process of developing a long life supercapacitor, a summary of which will be covered in a video presentation on R&D to be released by the Company today.

Through ongoing R&D, CAP-XX believes a truly long life supercapacitor is close to reality. The technology that makes up the new long life supercapacitor product uses IP developed by CAP-XX that is currently the subject of patent applications. Experimentation to date has shown that such a device could have an estimated life span of 30 years continuous operation at 30 degrees Celsius or more than 3 times current life.

Further development work is underway to improve operating windows for devices made with this technology. Development work is also underway into the modifications required to existing manufacturing lines to produce the product for market. These improvements will be applied to our existing product lines including the new PIP2 and Thinline products.

It is expected the initial launch product for the long life supercapacitor technology will be in the small form factor devices of between 0.1 and 3 Farads, similar in size and shape to devices currently sold by CAP-XX. The markets for such a device are in smart meters, smart buildings, medical devices, solid state drives and automotive applications, where product life performance criteria are often very demanding.

Further R&D work will be conducted throughout 2016 and samples for customer evaluation are expected to be delivered in H2 2016. The official product launch is anticipated as middle of 2017.

The video will be available at: Proactive Investors on http://www.proactiveinvestors.co.uk/companies/stocktube/4505/cap-xx-vp-on-product-development-4505.html and on the CAP-XX website shortly.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer)

+61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed

+44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley (Corporate Finance)

+44 (0) 20 3328 5656

 

 

Notes to Editors:

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKDDPKBDDFBB
Date   Source Headline
31st Oct 20244:35 pmRNSProposed Fundraising
21st Oct 20249:57 amRNSUpdate re. final results and current trading
16th Oct 20247:00 amRNSContract Win
5th Sep 20247:00 amRNSTrading Update and Notice of Results
30th Aug 20245:00 pmRNSTotal Voting Rights
14th Aug 20247:12 amRNSGrant of options
6th Aug 20249:18 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSExercise of warrants and total voting rights
29th Jul 20247:00 amRNSHolding(s) in Company
16th Jul 20247:00 amRNSMOU to establish technology partnership
18th Jun 20247:00 amRNSBoard Changes and Grant of Share Options
20th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSHolding(s) in Company
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.